InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Riley Brigit. Director active across 1 company, notably Adverum Biotechnologies, Inc.. Cumulatively, 2 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €13k. Activity tracked since 19 September 2022. The latest transaction was filed on 15 March 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations